GSK Lists Consumer Healthcare Unit in London

The video discusses the demerger of GSK and Pfizer, focusing on the implications for shareholders and the stock market. It outlines growth targets of 4-6% and strategies to achieve them, including leveraging consumer health categories. The video addresses concerns about debt ratios and financial strategies, highlighting plans to reduce leverage. It also explores potential M&A opportunities, particularly in the vitamins and supplements sector, and discusses market challenges such as inflation and consumer behavior.

What strategies are in place to manage the company's debt ratio?

How does the company plan to compete against private label products in the current market?

What opportunities for M&A does the company see in the vitamins, minerals, and supplements sector?